Expert Q&A: OneLab—Pathology Meets Virtual Reality
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
Keep up to date on new and emerging diagnostic tests, testing trends and opportunities, and disruptive technologies
CDC Virtual Reality Training lead Joe Rothschild discusses the new OneLab VR initiative—and the future of this project for the clinical lab
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
A recent study shows that most patients who underwent such screening were diagnosed at an earlier stage than those who did not.
A recent study shows that combined cardiomyopathy and arrhythmia genetic testing catches things disease-specific testing would miss.
For labs, the big takeaway is how prominently molecular testing and profiling figures in so many aspects of the NCCN’s recommendations.
The agency is advising people to perform repeat, or serial testing after a negative result, regardless of symptoms.
Two recent studies show that most people see telehealth as a supplement to in-person visits, rather than a replacement.
Without abortion rights, basic lab testing applications for those who are or want to become pregnant have new and ominous legal implications.
New tool helps determine whether immunotherapy is a better option for patients than chemotherapy or radiotherapy.
In a recent report, the GAO says the agency needs a policy when it comes to enforcement discretion regarding tests approved via EUA.